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Abstract 
It is unusual for acute disseminated encephalomyelitis and multiple sclerosis to 
present as purely psychiatric disorders. We report five patients with such 
demyelinating diseases and symptoms of psychosis, depression or anxiety. The 
importance of excluding demyelination as the basis for these psychiatric disturbances 
is emphasized, especially in the presence of unexplained neurologic findings. The 
possible relationship between psychiatric symptoms and demyelinating disorders is 
explored.  
 
 
 
Keywords: Disseminated encephalomyelitis; Multiple sclerosis; Psychosis; 
Depression; Generalized anxiety disorder  
Introduction 
A purely psychiatric syndrome may, on rare occasions, be the clinical presentation of 
multiple sclerosis (MS) and of acute disseminated encephalomyelitis (ADEM). These 
patients are often admitted to a psychiatric facility [1], [2] and [3], the presence of 
demyelinating lesions on MRI causes them to be referred for neurological evaluation. 
Depression, general anxiety disorder, bipolar disease, frank psychosis and personality 
disorders are not quite as rare as generally believed and may dominate the clinical 
picture [4]. Depression, as well as minor depressive symptoms and anxiety are the 
most commonly reported psychiatric manifestations [5] and [6].  
We describe five patients with ADEM or MS whose first symptoms were those of 
psychiatric illness.  
 
 
Case reports 
1. In April 2004, a previously healthy 39-year old secretary became fatigued and 
anxious; she had mood fluctuations, reduced short-term memory and learning ability. 
During the past 4 months she has lost 10 kg of weight. She denied any history of 
psychiatric illness, substance abuse, seizures, head injury, or exposure to poisons or 
toxins. In June, she visited a psychiatrist and was prescribed sertraline and 
alprazolam, but after 1 month she was admitted to a hospital because of deterioration 
of her mental state. During that period she became disoriented to time and place, 
confused, complaining of severe headaches, she had a blunted affect, but normal 
thought processes and content, and concerned about her illness. She had visual 
hallucinations. Suicidal ideation or intent was not present, nor was she aggressive. 
Neurological status was normal. Brain MRI showed very large, multiple, patchy, deep 
and subcortical white matter, parieto-occipital and temporal lesions bilaterally, more 
extensive on the right. CSF analysis revealed 104/3 lymphocytes, total protein level of 
69 mg per 100 ml and elevated intrathecal gamma globulin synthesis with positive 
oligoclonal bands. HIV and hepatitis B and C serology were negative. The diagnosis 
of ADEM was made and she was treated with IV methylprednisolone with only mild 
improvement of cognitive function. 
In July 2004, she was still disoriented to time and place. The most striking deficits 
were reduced short-term memory and inability to learn new information. She had no 
insight into her illness and had constant delusions and hallucinations. After 
consultation with a psychiatrist, she was given first, olanzapine and haloperidol, then 
promazine and zolpidem. Laboratory tests including: ACE, immunological tests 
(ASTA, ANF, ANCA, ENA, RF, Jo-1, anticardiolipin antibodies), complement levels, 
serum and CSF viral serology (CMV, EBV), serum and CSF toxoplasma, borrelia and 
fungal serology and cultures were all normal. Free T4 and TSH levels, and thyroid 
ultrasound were normal. Visual evoked potential latencies were prolonged bilaterally. 
Repeat brain MR T2 weighted images showed very large, patchy hyperintense, 
periventricular white matter lesions, with confluence in both occipital lobes (Fig. 1). 
Significant improvement of her mental state occurred after treatment with IV 
immunoglobulin and methylprednisolone together with psychiatric drugs; she no 
longer had delusions or hallucinations, but still had significant difficulty with recent 
memory and learning. Follow-up MRI in September showed improvement, no signs 
of new or enhancing lesions.  
2. A 44-year-old electrician was admitted to a psychiatric service in October 2002. He 
had been described by his family as acting strangely, disoriented, confused, and 
thinking he was the Pope. There was no history of psychiatric illness or substance 
abuse. Mental status revealed anxiety with expansive affect. Speech was spontaneous 
and elaborative. Thought process was characterized by looseness of association, flight 
of ideas and racing, and thought content was characterized by grandiose and religious 
delusions. Suicidal ideation or intent was absent. Neurological examination showed 
right spastic-ataxic hemiparetic gait. Brain MRI revealed hyperintense lesions in the 
insula. In April 2003, he again had delusions and was readmitted to a psychiatric 
service. CSF examination was performed and revealed a total protein level of 49 mg 
per 100 ml and positive oligoclonal bands. Serology tests for Borrelia and viruses 
(Herpes simplex 1 and 2, mumps, coxsackie, adeno, echo, polio, Central European) 
were negative. Visual evoked potentials were normal. He was diagnosed with ADEM 
and prescribed olanzapine. 
In July 2003, he was admitted to a neurology service. His neurological exam and 
mental status were normal. Immunological tests (CRP, AST, RF, ANF, ENA, ANCA, 
anticardiolipin antibodies) and thyroid function tests were normal. Brain MRI showed 
two non-enhancing lesions in the left periventricular frontal white matter (Fig. 2A). 
One year later, he was without symptoms and brain MRI performed in July 2004 
showed no changes.  
3. A 53-year-old woman had a 5-year history of MS based on transient gait difficulty 
without signs of pyramidal tract involvement, but with periventricular demyelination 
on MRI (Fig. 3A). She was admitted in March 2001 because of progressive gait 
disturbances, demanding corticosteroid therapy. Because signs of pyramidal lesion 
were absent and she expressed paranoid ideation, she was treated with saline 
infusions. During hospitalization, she developed the full-blown picture of paranoid 
psychosis. Her mental status was characterized by partial orientation in time, flat 
affect, short attention span, persecutory delusions (“my ex-boss is stalking me”), and 
frightening auditory and tactile hallucinations. During the interview speech was 
halted, often stopping in midsentence and then picked up a moment later. Suicidal 
ideation or intent was absent, and she was not aggressive. Brain MRI revealed two 
demyelinating enhancing lesions in the right parietal cortex (Fig. 3B). There were no 
changes in the previously reported lesions. Antipsychotic treatment was initiated with 
risperidone, olanzapine and haloperidol. There was improvement of her mental status 
and of her gait, but the antipsychotic drugs affected her liver enzymes. Immediately 
after discontinuation of the treatment, she again developed walking difficulties with 
very peculiar leg movements, and expressed fear of walking. Her mental state also 
deteriorated. After treatment with quetiapin her neurological exam returned to normal. 
Her diagnosis was confirmed as MS. 
4. In October 1998, 6 months after giving birth, a previously healthy, 34-year-old 
woman architect, became depressed, stopped eating and breastfeeding her child, and 
had sleep disturbances. She was admitted to a psychiatric hospital and diagnosed with 
a major depression, but after 9 days, she voluntarily left the hospital, taking 
alprasolam and maprotilin. Brain MRI revealed multiple demyelinating lesions in the 
subcortical and periventricular white matter and in the brain stem (Fig. 2B). Her only 
symptoms were occasional paresthesiae of the right arm. Neurological examination 
revealed vertical nystagmus, instability in the Romberg position and tandem gait, and 
incoordination of the left arm and leg. The family history was positive for depression. 
CSF examination revealed 11/3 lymphocytes, a total protein level of 29 mg per 
100 ml, and elevated intrathecal gamma globulin synthesis with positive oligoclonal 
bands. Serum viral serology (polio, ECHO, coxsackie, mumps, varicella), serum and 
CSF Borrelia serology and serum Mycoplasma serology, immunologic tests (AST, 
ASTA, ANF, anti-dsDNA, RF, anticardiolipin antibodies), ACE, thyroid function 
tests were all normal or negative. Visual evoked potential latencies were prolonged on 
the left. She was diagnosed as having MS. Re-examination in July 2000 was 
unchanged, but she was still depressed. 
5. In October 2001, a previously healthy woman teacher was seen because of a history 
of anxiety symptoms, insomnia, poor concentration, fatigue, hypervigilance, 
palpitations and sweating, for the past 7 months. She noted the onset of gait 
instability, and had had one episode of syncope, in the previous 2 weeks. 
Demyelinating lesions in the parietal periventricular and in left crus cerebri were 
noted on MRI (Fig. 2C). CSF examination revealed a total protein level of 21 mg per 
100 ml and positive oligoclonal bands. The serum level of ACE (69 U/l; normal 8-52) 
was elevated, and positive titer of ANF (l:16) was found. Serum viral serology 
revealed a highly positive IgG EBV-EBNA, indicative of a past EBV infection, but 
other viral titers (Adeno, ECHO, coxsackie, varicella, parotitis, Borrelia) were 
normal. Visual evoked potential latencies were normal. Thyroid function tests were 
normal. She was diagnosed as having ADEM. 
 
 
Discussion 
During last decade considerable attention has been devoted to cognitive and 
psychiatric impairment in MS, however these aspects have been ignored in regard to 
ADEM. Diaz-Olavarrieta et al. [7] evaluated 44 MS patients who were stable between 
relapses and found neuropsychiatric symptoms in 95% of them, the most common 
being depression (79%), agitation (40%), anxiety (37%), irritability (35%), apathy 
(20%), euphoria (13%), disinhibition (13%), hallucinations (10%), aberrant motor 
behavior (9%), and delusions (7%). Asghar-Ali et al. [8] described two patients, 
without a previous history of psychiatric disorders, were first thought to have bipolar 
disorder, but were diagnosed as MS after brain MRI and CSF examinations. Another 
interesting finding is that the percentage of psychiatric patients with white matter 
abnormalities recorded by MRI consistent with MS is almost 15 times the reported 
prevalence of MS in the United States [9]. The significance of these figures is open to 
question since MRI interpretation so frequently does not differentiate between MS 
and ADEM [10] and [11]. It has not been possible to verify if all the cases cited below 
truly have MS or may be instances of ADEM. There appears to be only a single report 
of a psychotic state as the presenting manifestation of a clearly identified case of 
ADEM [12].  
The nature of the relationship between psychiatric problems and demyelinating 
lesions on MRI is still unresolved. While a causative link may exist, it is also possible 
that the two are unrelated and purely coincidental. Data from our patients are highly 
suggestive of a causative link. The fact that our first three patients had only 
psychiatric disturbances without any neurological abnormalities makes us favor the 
former.  
Treatment of psychosis in ADEM or MS is another unresolved issue. Published 
reviews suggest that clozapine should be the treatment of choice, although some 
authors suggest ziprasidone, one of the newer antipsychotic agents [13] and [14]. Our 
two patients with psychosis were treated with olanzapine, and patient 2 responsed best 
to that drug.  
Depression is the most common psychiatric symptom of MS, but there are some 
reasons to believe it may be the result of demyelination: depression is more common 
in MS patients than in other neurological and non-neurological diseases [6] and [15], 
MS patients with brain lesions have more depressive symptoms than those with 
predominant spinal cord involvement [16], in many MS patients, depression precedes 
and accompanies the attacks, and wanes during remissions [17], and several studies 
have shown a correlation between depression in MS patients and lesions in specific 
areas of the brain [18] and [19].  
The etiological mechanism of the depression in MS is still unclear, but there are some 
reports that indicate that cortical-subcortical disconnection in the projections areas of 
the limbic system may be responsible [20]. Correlation with lesion load in the 
temporal regions has also been suggested [21]. The type of clinical course does not 
influence the affective or cognitive state of MS patients [22], but depression is one of 
the strongest predictor of reduced quality of life [23], although as a rule the symptoms 
respond well to standard treatment [24].  
Although in many patients anxiety is merely a reactive response to the disability due 
to the underlying disease, the clinical picture of our patient 5 suggests that a causative 
link may exist between anxiety and MS. Anxiety and the association between anxiety 
and brain MRI changes in MS have not been studied as extensively as depression. 
Most published studies found similar levels of anxiety among MS patients and normal 
controls, and no correlation between the symptoms of anxiety and either brain MRI 
abnormalities or clinical variables [20] and [25]. However, Riether emphasizes that 
anxiety is frequently overlooked in MS patients, especially that induced by treatment 
with corticosteroids [26].  
 
 
Conclusion 
These cases demonstrate that both MS and ADEM represent a small, but significant 
proportion of all psychiatric patients. Clinicians should keep this in mind, especially 
in regard to patients presenting with psychiatric symptoms associated with 
unexplained neurological findings. Neuroimaging and other studies may reveal 
underlying demyelination requiring specific diagnostic work-up and therapy.  
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Figures 
Fig. 1. Case 1: MRI, July 2004.  
 
 
Fig. 2. (A) Case 2: MRI, July 2004; (B) Case 4: MRI, November 1999; (C) Case 5: 
MRI, April 2002.  
 
 
Fig. 3. Case 3: (A) MRI, November 2000; (B) MRI, October 2003.  
 
 
